ABBV-552
ABBV-552 is an SV2A modulator which is being evaluated to target nerve terminals to enhance synaptic efficiency. The mechanism is being evaluated for the potential treatment of cognitive impairment and other symptoms associated with a range of neuropsychiatric and neurodegenerative disorders.
Type of Molecule
Small MoleculeTarget
SV2AProduct Type
New Indication| Potential Indication | Region | Phase (1, 2, 3, Submitted) |
|---|---|---|
| Alzheimer's Disease | n/a |
Phase 1
|